Bioretec Files for CE Mark for its Bioresorbable RemeOs Magnesium Screw in the EU
Bioretec’s target is to receive the CE mark and to introduce the bioresorbable magnesium alloy trauma screw into the markets in the European Union during 2022.
Medical Device News Magazine reports breaking biotechnology news including new biotech developments, pharmaceuticals and more.
Bioretec’s target is to receive the CE mark and to introduce the bioresorbable magnesium alloy trauma screw into the markets in the European Union during 2022.
Omeros received approximately $126 million in cash at closing. In addition, Omeros retains and is entitled to collect the full amount of its accounts receivable outstanding as of today’s closing.
The GMP Facility for commercial manufacturing CAR-T Cell therapy and R&D Center for further pipeline development are constituting the 17,325 square-meter site of CAR-T Center.
This exciting product line will add new dimensions to Neoss existing Bone Regeneration offering, providing an enhanced offering of Bone materials and membranes.
USMI & JCRI have developed a Humidified Electrical Reactive Oxygen System (The Canady Helios™ Cold Plasma HERO™ System) which generates an ionized cold plasma mixed with the Air/O2 from oxygen sources such as hospital ventilators, CPAPs (Continuous Positive Airway Pressure), BIPAPs (Bilevel Positive Airway Pressure) or O2 face masks.
Medtecs notes the world has been hit again by the resurgence in confirmed COVID-19 cases brought about by the highly contagious Delta variant. The number